In this Buddisode, we sit down with Dr. Melissa Lechner from the Division of Endocrinology, Diabetes, and Metabolism at the UCLA David Geffen School of Medicine to discuss her recent paper about the mechanisms behind immune checkpoint inhibitor-induced autoimmune thyroiditis.
Check out our memes on Facebook (@antibuddies), Twitter (@antibuddiesP), and Instagram (@AntibuddiesPodcast).
Website: Antibuddies – Science Communication & Immunology (Antibuddies.org)
Check out our YouTube channel: https://www.youtube.com/channel/UCxyrHotyyY3sSwcp1zigeCw
Send us your queries/questions/suggestions at email@example.com.
Article of discussion: Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy – PubMed (nih.gov)
Leave a Reply